Production (Stage)
KP Tissue Inc.
KPT.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | -- | -- | -- |
| Total Receivables | 1.25M | 1.25M | 1.65M | 1.58M | 1.74M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.25M | 1.25M | 1.65M | 1.58M | 1.74M |
|
|
|||||
| Total Current Assets | 1.25M | 1.25M | 1.65M | 1.58M | 1.74M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 49.22M | 49.56M | 53.94M | 54.02M | 53.92M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.25M | 1.25M | 1.61M | 1.54M | 1.70M |
| Total Other Current Liabilities | 1.25M | 1.25M | 1.61M | 1.54M | 1.70M |
| Total Current Liabilities | 1.25M | 1.25M | 1.61M | 1.54M | 1.70M |
|
|
|||||
| Total Current Liabilities | 1.25M | 1.25M | 1.61M | 1.54M | 1.70M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.25M | 1.25M | 1.61M | 1.54M | 1.70M |
|
|
|||||
| Common Stock & APIC | 116.63M | 116.47M | 124.00M | 122.36M | 123.64M |
| Retained Earnings | -81.52M | -81.09M | -83.94M | -82.34M | -83.79M |
| Treasury Stock & Other | 12.86M | 12.93M | 12.27M | 12.46M | 12.38M |
| Total Common Equity | 47.97M | 48.31M | 52.34M | 52.49M | 52.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 47.97M | 48.31M | 52.34M | 52.49M | 52.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 47.97M | 48.31M | 52.34M | 52.49M | 52.22M |
|
|
|||||